CN115590908B - Traditional Chinese medicine composition, antibacterial spray and preparation method - Google Patents

Traditional Chinese medicine composition, antibacterial spray and preparation method Download PDF

Info

Publication number
CN115590908B
CN115590908B CN202211275477.1A CN202211275477A CN115590908B CN 115590908 B CN115590908 B CN 115590908B CN 202211275477 A CN202211275477 A CN 202211275477A CN 115590908 B CN115590908 B CN 115590908B
Authority
CN
China
Prior art keywords
parts
chinese medicine
traditional chinese
medicine composition
antibacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202211275477.1A
Other languages
Chinese (zh)
Other versions
CN115590908A (en
Inventor
贺英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Jiadi Biological Group Co ltd
Original Assignee
Jiangsu Jiadi Biological Group Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Jiadi Biological Group Co ltd filed Critical Jiangsu Jiadi Biological Group Co ltd
Priority to CN202211275477.1A priority Critical patent/CN115590908B/en
Publication of CN115590908A publication Critical patent/CN115590908A/en
Application granted granted Critical
Publication of CN115590908B publication Critical patent/CN115590908B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/36Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/538Schizonepeta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605Morus (mulberry)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/65Paeoniaceae (Peony family), e.g. Chinese peony
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition, an antibacterial spray and a preparation method thereof, wherein the traditional Chinese medicine composition comprises the following components in parts by weight: 12-18 parts of purslane, 8-12 parts of red paeony root, 8-12 parts of mulberry leaf, 6-9 parts of herba schizonepetae, 10-15 parts of fringed pink, 2-4 parts of liquorice and 2-4 parts of Chinese angelica; the antibacterial spray comprises, by mass, 5-8% of the traditional Chinese medicine composition, 0.5-1.5% of clotrimazole, 0.1-0.5% of borneol and the balance of auxiliary materials. The traditional Chinese medicine composition provided by the invention has reasonable compatibility, and has good antibacterial and anti-bacterial properties and wound healing promoting properties due to the cooperation of seven medicines. The antibacterial spray is prepared by combining traditional Chinese medicine components and broad-spectrum antifungal medicines, has remarkable effect of treating candida vulvovaginitis, has cure rate of 78.33%, and has the effects of consolidating curative effects and reducing recurrence; meanwhile, compared with the single use of the traditional Chinese medicine composition, the antibacterial spray has better treatment effect on promoting the healing of wounds.

Description

Traditional Chinese medicine composition, antibacterial spray and preparation method
Technical Field
The invention relates to the field of personal care and medical supplies, in particular to a traditional Chinese medicine composition, an antibacterial spray and a preparation method thereof.
Background
Candida vulvovaginitis is a common and frequently-occurring disease of gynecology and is mainly caused by candida albicans, and clinically mainly appears as pruritus vulvae, burning sensation, increased leucorrhea, thickened leucorrhea which is in a curd or bean curd residue shape, and can also be accompanied with frequent urination, painful urination and dyspareunia. This is one of the most commonly affected diseases in adult females and belongs to the categories of "under-the-belt" and "pruritus vulvae" in TCM.
In recent years, reproductive health of men and women has become a focus of public attention, and various gynecological antibacterial products are developed in the market successively, and are popular with consumers. In order to seek out medicines with quick effect, small irritation and small side effect, researchers have carried out a great deal of research on the medicines, but the single use of Chinese herbal medicines mostly cannot achieve very high curative effect and has recurrent problems.
The inventor discovers that a traditional Chinese medicine composition has good antibacterial and bactericidal performance through researches in recent years, and can improve the curative effect, reduce side effects, consolidate the curative effect and reduce relapse through combining the traditional Chinese medicine and western medicine with antifungal medicines to treat candida vulvovaginitis.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provide a traditional Chinese medicine composition, an antibacterial spray and a preparation method thereof, so as to solve the problems in the technical background.
In order to achieve the above object, the present invention is realized by the following technical scheme:
on the one hand, the invention provides a traditional Chinese medicine composition, which comprises the following components in parts by weight: 12-18 parts of purslane, 8-12 parts of red paeony root, 8-12 parts of mulberry leaf, 6-9 parts of herba schizonepetae, 10-15 parts of fringed pink, 2-4 parts of liquorice and 2-4 parts of Chinese angelica.
In the technical scheme, the composition comprises the following components in parts by weight: 15 parts of purslane, 10 parts of red paeony root, 10 parts of mulberry leaf, 8 parts of schizonepeta, 12 parts of fringed pink, 3 parts of liquorice and 3 parts of Chinese angelica.
In the technical scheme, the traditional Chinese medicine composition is a concentrated solution which is obtained by mixing the contained components in proportion, extracting with water, and concentrating 1-2 g/ml.
In the formula, purslane has the effects of clearing heat and detoxicating, red paeony root has the effects of clearing heat and relieving pain and cooling blood and removing blood stasis, and the two medicines are compatible and used as monarch medicines; mulberry leaf and schizonepeta have the effects of dispelling wind and relieving itching, and are jointly ministerial drugs; the fringed pink is used as an adjuvant drug for clearing heat and eliminating dampness; glycyrrhrizae radix and radix Angelicae sinensis are used as guiding drug for nourishing blood, promoting blood circulation, warming channel and dredging collaterals. The seven medicines cooperate to show strict and proper compatibility of the formula. The composition has the functions of clearing heat, eliminating dampness, killing parasites, relieving itching, astringing and stopping leukorrhagia.
On the other hand, the invention also provides an antibacterial spray, which comprises 5-8% of the traditional Chinese medicine composition according to any one of claims 1-3, 0.5-1.5% of clotrimazole, 0.1-0.5% of borneol and the balance of auxiliary materials according to mass percentage.
In the technical scheme, the auxiliary materials are polyethylene glycol 4000, propylene glycol, ethanol and distilled water.
On the other hand, the invention also provides a preparation method of the antibacterial spray, which comprises the following steps:
step one, preparation of a traditional Chinese medicine composition: weighing purslane parts, red paeony root, mulberry leaf, fineleaf schizonepeta herb, fringed pink, liquorice and Chinese angelica according to a proportion, soaking in water, decocting with 8-10 times of water for 3 times, combining the filtrates, and then shrinking to obtain 1-2 g/ml concentrated solution;
and step two, weighing clotrimazole, borneol, polyethylene glycol 4000, propylene glycol, ethanol and distilled water according to a proportion, adding the concentrated solution obtained in the step one, mixing and stirring uniformly, and filling to obtain the antibacterial spray.
One of the innovations of the invention is: the formula of the traditional Chinese medicine composition has the functions of clearing heat and detoxicating, and the red paeony root has the effects of clearing heat and relieving pain and cooling blood and removing blood stasis, and the two medicines are compatible and are monarch medicines; mulberry leaf and schizonepeta have the effects of dispelling wind and relieving itching, and are jointly ministerial drugs; the fringed pink is used as an adjuvant drug for clearing heat and eliminating dampness; glycyrrhrizae radix and radix Angelicae sinensis are used as guiding drug for nourishing blood, promoting blood circulation, warming channel and dredging collaterals. The seven medicines cooperate, so that the traditional Chinese medicine composition not only has good antibacterial performance, but also can promote wound healing.
The innovation of the invention is that: by compounding the traditional Chinese medicine composition with clotrimazole, the effect of treating candida vulvovaginitis is remarkable, the curative effect is consolidated, and the recurrence is reduced; meanwhile, the curative effect on wound healing is obviously higher than that obtained by singly using the traditional Chinese medicine composition.
Compared with the prior art, the invention has the beneficial effects that:
1. the traditional Chinese medicine composition provided by the invention has reasonable compatibility, purslane has the effects of clearing heat and detoxicating, red paeony root has the effects of clearing heat and relieving pain and cooling blood and removing stasis, and the compatibility of the two medicines is monarch medicine; mulberry leaf and schizonepeta have the effects of dispelling wind and relieving itching, and are jointly ministerial drugs; the fringed pink is used as an adjuvant drug for clearing heat and eliminating dampness; glycyrrhrizae radix and radix Angelicae sinensis are used as guiding drug for nourishing blood, promoting blood circulation, warming channel and dredging collaterals. The seven medicines cooperate to mainly treat the diseases of clearing heat and drying dampness, killing parasites and relieving itching, astringing and stopping leukorrhagia, and has good antibacterial and anti-bacterial properties and wound healing promoting properties.
2. The antibacterial spray provided by the invention combines traditional Chinese medicine components and broad-spectrum antifungal medicines, is prepared after compounding, has remarkable effect of treating candida vulvovaginitis, has a cure rate of 78.33%, and has the effects of consolidating curative effects and reducing recurrence; meanwhile, the traditional Chinese medicine component is combined with the broad-spectrum antifungal clotrimazole, and the antibacterial spray prepared after compounding has better treatment effect on promoting wound healing compared with the traditional Chinese medicine composition adopted alone.
Drawings
FIG. 1 is a bar graph of the composition of application example 1 against Candida albicans zone;
fig. 2 is a graph showing the dynamic change of the influence of the antibacterial spray on the wound healing rate in application example 4.
Detailed Description
Other advantages and effects of the present invention will become apparent to those skilled in the art from the following disclosure, which describes the embodiments of the present invention with reference to specific examples. The invention may be practiced or carried out in other embodiments that depart from the specific details, and the details of the present description may be modified or varied from the spirit and scope of the present invention. It should be noted that the following embodiments and features in the embodiments may be combined with each other without conflict. The term "parts" means any mass, which is used only to distinguish between the different components, and may be 0.1g, 1kg,1000kg, etc.
Chinese medicinal composition
Example 1
A traditional Chinese medicine composition comprises the following components in parts by weight: 12 parts of purslane, 12 parts of red paeony root, 8 parts of mulberry leaf, 9 parts of schizonepeta, 10 parts of fringed pink, 4 parts of liquorice and 4 parts of Chinese angelica.
Example 2
A traditional Chinese medicine composition comprises the following components in parts by weight: 15 parts of purslane, 10 parts of red paeony root, 10 parts of mulberry leaf, 8 parts of schizonepeta, 12 parts of fringed pink, 3 parts of liquorice and 3 parts of Chinese angelica.
Example 3
A traditional Chinese medicine composition comprises the following components in parts by weight: 18 parts of purslane, 8 parts of red paeony root, 12 parts of mulberry leaf, 6 parts of schizonepeta, 15 parts of fringed pink, 2 parts of liquorice and 2 parts of Chinese angelica.
Comparative example 1
This comparative example is similar to example 2, except that purslane was omitted, specifically: a traditional Chinese medicine composition comprises the following components in parts by weight: 10 parts of red paeony root, 10 parts of mulberry leaf, 8 parts of herba schizonepetae, 12 parts of fringed pink, 3 parts of liquorice and 3 parts of Chinese angelica.
Comparative example 2
This comparative example is similar to example 2, except that red peony root is deleted, specifically: a traditional Chinese medicine composition comprises the following components in parts by weight: 15 parts of purslane, 10 parts of mulberry leaf, 8 parts of herba schizonepetae, 12 parts of fringed pink, 3 parts of liquorice and 3 parts of Chinese angelica.
Comparative example 3
This comparative example is similar to example 2, except that the leaves of the mulberry are deleted, specifically: a traditional Chinese medicine composition comprises the following components in parts by weight: 15 parts of purslane, 10 parts of red paeony root, 8 parts of schizonepeta, 12 parts of fringed pink, 3 parts of liquorice and 3 parts of Chinese angelica.
Comparative example 4
This comparative example is similar to example 2, except that the herba Schizonepetae was deleted, specifically: a traditional Chinese medicine composition comprises the following components in parts by weight: 15 parts of purslane, 10 parts of red paeony root, 10 parts of mulberry leaf, 12 parts of fringed pink, 3 parts of liquorice and 3 parts of Chinese angelica.
Comparative example 5
This comparative example is similar to example 2, except that the fringed pink herb is deleted, specifically: a traditional Chinese medicine composition comprises the following components in parts by weight: 15 parts of purslane, 10 parts of red paeony root, 10 parts of mulberry leaf, 8 parts of schizonepeta, 3 parts of liquorice, and 3 parts of Chinese angelica.
The formulations of the traditional Chinese medicine compositions prepared by the raw materials of the examples 1-3 and the comparative examples 1-5 are shown in the table 1, and are prepared by the following methods: firstly, soaking all raw material components (the raw material formulas provided in examples 1-3 and comparative examples 1-5) in water for 0.5-1 h, decocting with 8-10 times of water for 3 times, mixing filtrates, and then shrinking to obtain 1-2 g/ml concentrated solution.
TABLE 1
Group of Formulation of
Example 1 12 parts of purslane, 12 parts of red paeony root, 8 parts of mulberry leaf, 9 parts of schizonepeta, 10 parts of fringed pink, 4 parts of liquorice and 4 parts of Chinese angelica
Example 2 15 parts of purslane, 10 parts of red paeony root, 10 parts of mulberry leaf, 8 parts of schizonepeta, 12 parts of fringed pink, 3 parts of liquorice and 3 parts of Chinese angelica
Example 3 18 parts of purslane, 8 parts of red paeony root, 12 parts of mulberry leaf, 6 parts of schizonepeta, 15 parts of fringed pink, 2 parts of liquorice and 2 parts of Chinese angelica
Comparative example 1 10 parts of red paeony root, 10 parts of mulberry leaf, 8 parts of herba schizonepetae, 12 parts of fringed pink, 3 parts of liquorice, 3 parts of Chinese angelica
Comparative example 2 15 parts of purslane, 10 parts of mulberry leaf, 8 parts of herba schizonepetae, 12 parts of fringed pink, 3 parts of liquorice, and 3 parts of Chinese angelica
Comparative example 3 15 parts of purslane, 10 parts of red paeony root, 8 parts of herba schizonepetae, 12 parts of fringed pink, 3 parts of liquorice, 3 parts of Chinese angelica
Comparative example 4 15 parts of purslane, 10 parts of red paeony root, 10 parts of mulberry leaf, 12 parts of fringed pink, 3 parts of liquorice, 3 parts of Chinese angelica
Comparative example 5 15 parts of purslane, 10 parts of red paeony root, 10 parts of mulberry leaf, 8 parts of schizonepeta, 3 parts of liquorice, 3 parts of angelica
Determination of bacteriostatic efficacy of the composition of application example 1
Antibacterial efficacy test: the antibacterial activity of the compositions obtained in examples 1 to 3 and comparative examples 1 to 5 against Candida albicans was tested by an oxford cup agar diffusion method; candida albicans ATCC 10231, purchased from south kyo music diagnosis biotechnology limited;
the test method comprises the following steps: setting 10 groups of experiments, namely 1 negative control group, 1 positive control group and 8 treatment groups; the negative control group is distilled water, the positive control group is bacitracin 200ug/ml, 8 treatment groups are respectively concentrated solutions obtained in examples 1-3 and comparative examples 1-5 which are diluted by 10 times for 2 g/ml; each sample was repeated 5 times, 200ul of the corresponding solution was added to each group of oxford cups, and the mixture was placed in a refrigerator at 4 ℃ for 4 hours to spread the solution, and then incubated at 37 ℃ for 16 to 18 hours, the diameter of the inhibition zone was observed and measured, and the average value of 5 times of the inhibition zone was taken, as shown in table 2 and fig. 1.
Table 2 diameter of zone of inhibition/mm for compositions against Candida albicans
Group of Diameter of bacteriostasis ring
Negative control group /
Positive control group 16.63±0.82 a
Example 1 20.93±0.94 ab
Example 2 21.42±1.01 ab
Example 3 21.15±0.99 ab
Comparative example 1 13.54±0.85
Comparative example 2 12.05±0.78
Comparative example 3 13.41±0.87
Comparative example 4 12.85±0.77
Comparative example 5 13.07±0.69
Note that: a: p <0.05 compared to any of comparative examples 1-5; b: p <0.05 compared to the positive control group.
As can be seen from Table 2 and FIG. 1, the compositions obtained in examples 1-3 have good antibacterial activity against Candida albicans, and the antibacterial effect of the compositions obtained in examples 1-3 on Candida albicans is significantly higher than that of the positive control group. Meanwhile, compared with comparative examples 1-5, the antibacterial effect of the composition obtained in examples 1-3 on candida albicans is obviously improved, which proves that the synergistic effect of the components of the composition obtained in the invention improves the antibacterial performance of the composition on candida albicans. In the invention, purslane in the formula of the composition has the effects of clearing heat and detoxicating, red paeony root has the effects of clearing heat and relieving pain and cooling blood and removing blood stasis, and the two medicines are compatible and are monarch medicines; mulberry leaf and schizonepeta have the effects of dispelling wind and relieving itching, and are jointly ministerial drugs; the fringed pink is used as an adjuvant drug for clearing heat and eliminating dampness; glycyrrhrizae radix and radix Angelicae sinensis are used as guiding drug for nourishing blood, promoting blood circulation, warming channel and dredging collaterals. The seven medicines cooperate, the precise and appropriate compatibility of the prescription is reflected, and the traditional Chinese medicine composition is mainly used for clearing heat and drying dampness, killing parasites and relieving itching, astringing and stopping leukorrhagia and has good antibacterial performance.
Antibacterial spray
The embodiment 4 of the application provides an antibacterial spray, which comprises, by mass percent, 7% of the traditional Chinese medicine composition described in the embodiment 2, 1% of clotrimazole, 0.2% of borneol and the balance of auxiliary materials. Wherein the auxiliary materials are polyethylene glycol 4000, propylene glycol, ethanol and distilled water.
In this embodiment, the preparation method of the antibacterial spray includes the following steps:
step one, preparation of a traditional Chinese medicine composition: weighing purslane parts, red paeony root, mulberry leaf, fineleaf schizonepeta herb, fringed pink, liquorice and Chinese angelica according to a proportion, soaking in water, decocting with 8-10 times of water for 3 times, combining the filtrates, and then shrinking to obtain 1-2 g/ml concentrated solution;
and step two, weighing clotrimazole, borneol, polyethylene glycol 4000, propylene glycol, ethanol and distilled water according to a proportion, adding the concentrated solution obtained in the step one, mixing and stirring uniformly, and filling the mixture, wherein the specification of each bottle is 25ml, thus obtaining the antibacterial spray.
The embodiment 5 of the application provides an antibacterial spray, which comprises 5% of the traditional Chinese medicine composition described in the embodiment 2, 1.5% of clotrimazole, 0.1% of borneol and the balance of auxiliary materials in percentage by mass. Wherein the auxiliary materials are polyethylene glycol 4000, propylene glycol, ethanol and distilled water.
The embodiment 6 of the application provides an antibacterial spray, which comprises, by mass percent, 8% of the traditional Chinese medicine composition described in the embodiment 2, 0.5% of clotrimazole, 0.5% of borneol and the balance of auxiliary materials. Wherein the auxiliary materials are polyethylene glycol 4000, propylene glycol, ethanol and distilled water.
The application comparative example 6 provides an antibacterial spray, which comprises 7% of the traditional Chinese medicine composition described in the example 2 by mass percentage, and the balance of auxiliary materials. Wherein the auxiliary materials are polyethylene glycol 4000, propylene glycol, ethanol and distilled water.
The application comparative example 7 provides an antibacterial spray, which comprises 1% of clotrimazole, 0.2% of borneol and the balance of auxiliary materials according to mass percentage. Wherein the auxiliary materials are polyethylene glycol 4000, propylene glycol, ethanol and distilled water.
Application example 2 vaginal mucosa irritation test of antibacterial spray
The experimental method comprises the following steps: selecting 35 female white rabbits which are healthy, adult and unmatched, dividing the experimental animals into 7 groups, namely 1 blank control group, 1 negative control group and 5 experimental groups, wherein each group comprises 5 animals; the rabbit vaginal orifice was checked prior to dosing for secretion, congestion, edema and other damage. The rabbits were fixed on the bottom to expose the perineum and the vaginal orifice, the hose was gently inserted into the vagina after wetting, 1.5ml of the antibacterial spray obtained in the corresponding examples 4 to 6 and comparative examples 6 to 7 was slowly injected into the test group by a syringe, the catheter was withdrawn after the completion of the administration, and the administration was repeated once every 24 hours for 7 days. The negative control group was treated with physiological saline as well, and the blank group was not treated at all. 24 hours after the last administration, animals are sacrificed, the complete vagina is taken out by laparotomy, longitudinal incision is carried out, and whether congestion, edema and the like appear is observed visually for reference when pathological materials are obtained. Then the vagina is put into 10% formalin solution for fixation for more than 24 hours, tissue sections of the two ends and the center of the vagina are selected, and after HE staining, histopathological examination is carried out.
Through observation of the experimental rabbits in each group, the experimental rabbits in each group have good general conditions, clean hair color, free movement, normal diet, weight increase, no abnormal secretion in vaginal mucosa, and no symptoms such as congestion, edema, necrosis and the like during the administration period. Pathological examination shows that the morphology of the vaginal mucosa epithelial cells of the rabbits in the blank control group is not abnormal, the blood vessel expansion is not seen, the leucocyte infiltration is not seen in the myometrium and adventitia layers, and the blood vessel congestion is not seen. The vaginal mucosa epithelial cells of the rabbits in the negative control group and the experimental group are slightly damaged, and the myometrium and the adventitia are infiltrated with a small amount of white blood cells, but the phenomena of inflammatory cell infiltration and tissue cell necrosis are avoided, and the phenomenon of drug stimulation reaction is eliminated. The antibacterial spray obtained in examples 4-6 and comparative examples 6-7 has no irritation to the complete vaginal mucosa group and the damaged vaginal mucosa group of rabbits.
Application example 3 observation of curative effect of antibacterial spray for treating mycotic vaginitis
Experimental grouping: 216 patients suffering from colpitis mycotica, which are married or sexual women (except pregnant women) with the age of 25-41 years, are selected and divided into 3 treatment groups and 1 control group, wherein 60 patients in each treatment group and 36 patients in the control group; the antibacterial spray obtained in example 4, comparative example 6 and comparative example 7 was used for 3 patients in the treatment group, and clotrimazole suppository (each containing 150mg of clotrimazole in Guangzhou He Ji metric pharmaceutical factory) was used in the control group;
the experimental method comprises the following steps: after washing the vulva and vagina with 2% -3% sodium bicarbonate solution, the vagina is widened by a vaginal device, and the corresponding medicament (the antibacterial spray obtained in example 4, comparative example 6 and comparative example 7) is uniformly sprayed into the vagina, 3-5 sprays/each time, 1 time a day. After the control group irrigated the vulva and vagina, clotrimazole was embolized into the deep vagina, 1 granule each time, 1 time per night. 4. Group patients all need to receive treatment for 7 days.
After treatment, the clinical results of patients are observed, and the curative effect standard is as follows: the external appearance of the leucorrhea is normal after healing, the vaginal congestion disappears, the symptoms of pruritus vulvae, burning pain and urgent urination pain are eliminated, the vaginal secretion is checked to turn into the mold and the cleanliness is I-II degrees after stopping the medicine, and the mold is still negative after checking the vaginal secretion after the next menstrual period.
Effective leucorrhea is reduced, all accompanying symptoms are relieved, vaginal secretion is checked to turn mold into yin 5 days after stopping medicine, but the patient recurs after the next menstrual period.
The leucorrhea is abnormal in appearance, the leucorrhea amount is still as much as bean dregs or curd shape, the symptoms are not improved, and the vaginal secretion is checked to be positive after 5 days of stopping the medicine. The observation results are shown in Table 3.
TABLE 3 therapeutic Effect of antibacterial sprays on mycotic vaginitis
Group of Number n of examples Healing of the wound Effective and effective Invalidation of Total effective rate
Control group 36 21(58.33) 11(30.56) 4(11.11) 32(88.89)
Example 4 60 47(78.33) 13(21.67) 0(0) 60(100)
Comparative example 6 60 38(63.33) 16(26.67) 6(10) 54(90)
Comparative example 7 60 29(48.33) 20(33.33) 11(18.33) 49(81.67)
As can be seen from table 3: the effective rate of the patient treated by the antibacterial spray obtained in the example 4 is 100%, and the cure rate is 78.33%; the effective rate of the patients in the control group is 88.89%, the cure rate is 58.33%, the total effective rate of the anti-bacteria spray obtained in the example 4 is obviously higher than that of the control group, and the anti-bacteria spray obtained in the example 4 has obvious curative effect; the total effective rate of the antibacterial spray obtained in the example 4 for patients treated by the antibacterial spray obtained in the comparative example 6-7 is higher than that of the antibacterial spray obtained in the comparative example 6-7, the effective rate of the antibacterial spray reaches 90%, the recovery rate is 63.33%, and the antibacterial spray obtained in the example 4 has a very remarkable effect compared with that of the comparative example 6-7, so that the antibacterial spray prepared after the traditional Chinese medicine composition and the clotrimazole are compounded has a synergistic effect.
Application example 4 test for anti-bacterial spray to promote wound healing
Experimental grouping: 50 Wistar rats weighing 180+/-20 g are bred for one week so as to adapt to new environment; the animals were divided into 3 administration groups, 1 blank control group and 1 positive control group, each group of 10 Wistar rats; the antibacterial spray obtained in example 4, comparative example 6 and comparative example 7 is adopted for 3 administration groups, the blank control group adopts conventional disinfection, and the positive control group adopts adhesive plaster;
the experimental method comprises the following steps: after one week of feeding, after anesthesia with diethyl ether, the dorsal mouse hair is removed, and a circular wound surface (to the deep fascia layer) with a diameter of 1cm is made with a tissue puncher; after the molding is successful, 3 administration groups spray the antibacterial spray obtained in the corresponding example 4, the comparative example 6 and the comparative example 7 on the wound of the molded rat respectively, wherein the spraying is 3 to 5 times, and the spraying is performed twice a day based on the skin of the wound; the blank control group is sterilized conventionally every day, 2% iodine tincture is coated, and the wound of the positive control group is coated with the adhesive plaster for generating muscle twice every day, and each time is coated with 1mm thick;
wound healing was observed n days after dosing (n=3, 5, 7, 9) and the degree of wound healing was calculated for each group of rats, with statistics shown in table 4 and fig. 2; the calculation formula of the healing degree is as follows:
wound healing degree (%) = [ (nth day wound area-initial wound area)/initial wound area ] ×100%
TABLE 4 dynamic change in wound healing Rate (%)
Group of 3d 5d 7d 9d
Blank control group 14.57±1.14 33.18±2.54 58.24±2.94 82.18±3.21
Positive control group 16.54±1.26 40.68±2.19 a 69.35±2.01 a 90.12±2.92 a
Example 4 17.14±1.32 42.94±2.63 a 78.13±1.65 abc 98.85±2.46 abc
Comparative example 6 15.36±1.02 36.12±2.47 64.46±2.52 a 88.41±2.13 a
Comparative example 7 14.23±1.28 31.56±1.83 56.72±2.74 78.27±2.48
Note that: a: p <0.05 compared to the placebo group; b: p <0.05 compared to comparative example 1; c: p <0.05 compared to the positive control group.
As can be seen from table 4 and fig. 2, there is no obvious difference between the groups after 3d, to 5d, the positive control group and example 4 showed significantly improved healing effect compared to the blank control group, to 7d and 9d, example 4 showed significantly improved healing effect compared to the positive control group, and comparative example 6 showed significantly improved healing effect compared to the blank control group; therefore, the purslane parts, the red paeony root, the mulberry leaf, the fineleaf schizonepeta herb, the fringed pink, the liquorice and the Chinese angelica have synergistic promotion effect on wound healing of rats, can obviously promote wound healing, and simultaneously, the traditional Chinese medicine components are combined with the broad-spectrum antifungal drug clotrimazole, and compared with the traditional Chinese medicine composition adopted alone, the antibacterial spray prepared after compounding has better treatment effect on promoting wound healing.
The above examples merely illustrate specific embodiments of the invention, which are described in more detail and are not to be construed as limiting the scope of the invention. It should be noted that it will be apparent to those skilled in the art that several variations and modifications can be made without departing from the spirit of the invention, which are all within the scope of the invention.

Claims (6)

1. The traditional Chinese medicine composition for inhibiting bacteria and promoting wound healing is characterized by being prepared from the following raw materials in parts by weight: 12-18 parts of purslane, 8-12 parts of red paeony root, 8-12 parts of mulberry leaf, 6-9 parts of herba schizonepetae, 10-15 parts of fringed pink, 2-4 parts of liquorice and 2-4 parts of Chinese angelica.
2. The antibacterial and wound healing promoting traditional Chinese medicine composition according to claim 1 is characterized by being prepared from the following raw materials in parts by weight: 15 parts of purslane, 10 parts of red paeony root, 10 parts of mulberry leaf, 8 parts of schizonepeta, 12 parts of fringed pink, 3 parts of liquorice and 3 parts of Chinese angelica.
3. The antibacterial and wound healing promoting traditional Chinese medicine composition according to claim 1, wherein the traditional Chinese medicine composition is a concentrated solution which is obtained by mixing the raw materials in proportion, extracting with water, and concentrating 1-2 g/ml.
4. The spray for inhibiting bacteria and promoting wound healing is characterized by comprising, by mass, 5-8% of the traditional Chinese medicine composition according to any one of claims 1-3, 0.5-1.5% of clotrimazole, 0.1-0.5% of borneol and the balance of auxiliary materials.
5. The antibacterial and wound healing promoting spray according to claim 4, wherein the auxiliary materials are polyethylene glycol 4000, propylene glycol, ethanol and distilled water.
6. The method for preparing the antibacterial and wound healing promoting spray according to claim 4, which is characterized by comprising the following steps:
step one, preparation of a traditional Chinese medicine composition: weighing purslane, red paeony root, mulberry leaf, fineleaf schizonepeta herb, fringed pink, liquorice and Chinese angelica according to a proportion, adding water for soaking, decocting for 3 times by 8-10 times of water, combining the filtrates, and concentrating to obtain a concentrated solution of 1-2 g/ml;
and step two, weighing clotrimazole, borneol, polyethylene glycol 4000, propylene glycol, ethanol and distilled water, adding the concentrated solution obtained in the step one, mixing and stirring uniformly, and filling to obtain the antibacterial spray.
CN202211275477.1A 2022-10-18 2022-10-18 Traditional Chinese medicine composition, antibacterial spray and preparation method Active CN115590908B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211275477.1A CN115590908B (en) 2022-10-18 2022-10-18 Traditional Chinese medicine composition, antibacterial spray and preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211275477.1A CN115590908B (en) 2022-10-18 2022-10-18 Traditional Chinese medicine composition, antibacterial spray and preparation method

Publications (2)

Publication Number Publication Date
CN115590908A CN115590908A (en) 2023-01-13
CN115590908B true CN115590908B (en) 2023-08-01

Family

ID=84848256

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211275477.1A Active CN115590908B (en) 2022-10-18 2022-10-18 Traditional Chinese medicine composition, antibacterial spray and preparation method

Country Status (1)

Country Link
CN (1) CN115590908B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101181481A (en) * 2007-12-06 2008-05-21 张治中 Chinese medicine preparation for curing dermatosis and preparation method thereof

Also Published As

Publication number Publication date
CN115590908A (en) 2023-01-13

Similar Documents

Publication Publication Date Title
CN1879831A (en) Bacteriostatic externally applied preparation for treating gynecological inflammation and method for preparing same
CN106692307B (en) Hydrogel for treating female cervical erosion and preparation method thereof
CN102631589B (en) Penyanxiao enema and preparation method thereof
CN1679687A (en) External-applied capsules for treating gynecopathy and preparation thereof
CN102846858A (en) Antibacterial pharmaceutical composition
CN115590908B (en) Traditional Chinese medicine composition, antibacterial spray and preparation method
CN102302505B (en) Medicinal composition for treating pelvic inflammatory disease and application thereof
CN104208242B (en) One treats prostatitic external use plaster and preparation method thereof
CN105106304A (en) Traditional Chinese medicine compound preparation for treating gynecological inflammations and preparation method thereof
CN102600456B (en) Bioadhesive vaginal plug for treating vaginitis and cervicitis as well as preparation method of bioadhesive vaginal plug
CN104306909B (en) Prevent and treat Chinese medicine composition of cattle uterus subinvolution and preparation method thereof
CN107854540B (en) External traditional Chinese medicine formula essential oil for treating haemorrhoids
CN106236959A (en) A kind of external-applied ointment treating hemorrhoid
CN101972451B (en) Compound infusion preparation of Chinese herbal medicines and western medicines for treating cow hysteritis and preparation method thereof
CN104840699A (en) Medicine composition for treating chronic pelvic inflammation
CN101391053B (en) Traditional Chinese medicine composition for treating hemorrhoid
CN116898940B (en) Traditional Chinese medicine composition for early treatment of non-lactation mastitis and preparation method thereof
CN102389557B (en) Chinese medicinal composition and Chinese medicinal ball for treating uterine cancer and application thereof
CN102028873B (en) Tannin berberine gel for treating cervical erosion and preparation process thereof
CN102988847A (en) Medicine composition used for treating vaginitis
CN101773581A (en) Medicine for treating female genitourinary system inflammation
CN108066570B (en) Traditional Chinese medicine extract for diminishing inflammation and relieving pain after haemorrhoid surgery and application thereof
CN100408085C (en) Snow lotus preparation for treating prostate disease
CN105832909A (en) Traditional Chinese medicine preparation for treating necrotic ulcer of skin
CN118217350A (en) Pharmaceutical composition for promoting tissue regeneration, preparation and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20230712

Address after: 212300 No.1, Hehe Road, Sanqiao Shen Village, Qu'a Street, Danyang City, Zhenjiang City, Jiangsu Province

Applicant after: Jiangsu Jiadi Biological Group Co.,Ltd.

Address before: 511500 No. 10-2, Guangzhou road, Guangzhou (Qingyuan) industrial transfer park, Shijiao Town, Qingcheng District, Qingyuan City, Guangdong Province

Applicant before: Guangdong Hanrun Biotechnology Co.,Ltd.

GR01 Patent grant
GR01 Patent grant